Komentář ke studii (Kardiovaskulární bezpečnost vildagliptinu u pacientů s diabetes mellitus 2. typu)

Abstrakt

Komentář ke studii: Williams R, de Vries F, Kothny W, et al. Cardiovascular safety of vildagliptin in patients with type 2 diabetes: a European multi-database, non-interventional post-authorization safety study.

Diabetes Obes Metab 2017 Mar 24 [Epub ahead of print].